Trial intelligence / Profile preview

Fluconazole in Hypercalcicuric Patients

NCT04495608Phase 2Completed

Sponsor
Hospices Civils de Lyon
Start
Jan 2021
Primary completion
Jul 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fluconazole in hypercalciuria, nephrolithiasis, nephrocalcinosis, sponsored by Hospices Civils de Lyon. Started Jan 2021; status: completed.

02

Drugs

fluconazole
03

Conditions

hypercalciurianephrolithiasisnephrocalcinosis

Beyond the preview

Go deeper on NCT04495608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04495608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call